MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE: BCR - News) today announced that it has closed the previously announced acquisition of the assets of the LifeStent® product family from Edwards Lifesciences Corporation, headquartered in Irvine, California. Bard will immediately commence marketing the products globally.
